Markov Random Field Models for Segmentation of PET Images. - Jun L. Chen; Steve R. Gunn; Mark S. Nixon; Roger N. Gunn (IPMI, 2001)

A Database of [11C]WAY-100635 Binding to 5-HT1A Receptors in Normal Male Volunteers: Normative Data and Relationship to Methodological, Demographic, Physiological, and Behavioral Variables. - Eugenii A. Rabiner; Cristina Messa; Peter A. Sargent; Karen Husted-Kjaer; Andrew Montgomery; Andrew D. Lawrence; Christopher J. Bench; Roger N. Gunn; Philip J. Cowen; Paul M. Grasby (NeuroImage, 2002)

Bootstrapped DEPICT for error estimation in PET functional imaging. - Sunil L. Kukreja; Roger N. Gunn (NeuroImage, 2004)

Wavelet variance components in image space for spatiotemporal neuroimaging data. - John A. D. Aston; Roger N. Gunn; Rainer Hinz; Federico E. Turkheimer (NeuroImage, 2005)

Statistical maps for EEG dipolar source localization. - Christian G. Bénar; Roger N. Gunn; Christophe Grova; Benoît Champagne 001; Jean Gotman (IEEE Trans. Biomed. Eng., 2005)

Within-subject comparison of striatal D2 receptor occupancy measurements using [123I]IBZM SPECT and [11C]Raclopride PET. - Ana M. Catafau; Marina Suárez; Santiago Bullich; Jordi Llop; Gianluca Nucci; Roger N. Gunn; Claire Brittain; Marc Laruelle (NeuroImage, 2009)

Differentiation of the Mu-opioid ligand GSK1521498 from naltrexone using [11C]carfentanil PET and fMRI. - John D. Beaver; Edward T. Bullmore; Graham E. Searle; Christopher J. Long; Samuel P. Hill; Jonathan Howard; Pradeep J. Nathan; Paul M. Matthews; Roger N. Gunn; Eugenii A. Rabiner (NeuroImage, 2010)

Comparison of nonlinear mixed effects and conventional least squares analyses of PET PK-receptor occupancy studies. - Alienor Berges; Vincent J. Cunningham; Roger N. Gunn; Stefano Zamuner (NeuroImage, 2010)

Impact of scatter correction on D2 receptor occupancy measurements using 123I-IBZM SPECT: Comparison to 11C-Raclopride PET. - Santiago Bullich; Albert Cot; J. Gallego; Roger N. Gunn; Marina Suárez; Javier Pavía; Domènec Ros; Marc Laruelle; Ana M. Catafau (NeuroImage, 2010)

Awake nonhuman primate brain PET imaging without head restraint. - Richard E. Carson; Christine Sandiego; Tim Mulnix; Xiao Jin; Krista Fowles; Shervin Liddie; Siobhan Ford; David Weinzimmer; David W. Campbell; Amanda Abbott; Marc Laruelle; Roger N. Gunn; et al. (NeuroImage, 2010)

PET evaluation of the TSPO ligands [F-18]FEPPA, [F-18]PRB06, and [F-18]PBR111 in nonhuman primate. - Richard E. Carson; David Weinzimmer; Andrei Koren; David Alagille; Krista Fowles; Sharon Ashworth; John P. Seibyl; Andrew Katsifis; Roger N. Gunn; Eugenii A. Rabiner; Sac-Pham Tang; Gilles Tamagnan (NeuroImage, 2010)

Uptake and regional distribution of [11C]rofecoxib in human brain. - Robert A. Comley; Jan Passchier; Anton Willemsen; Anders Wall; Mats Bergström; Bengt Långström; Jan Pruim; Maria Wishart; Eugenii A. Rabiner; Roger N. Gunn; Gunnar Antoni; Erik de Vries; et al. (NeuroImage, 2010)

In vivo binding of antipsychotics to D3 and D2 receptors: A PET study in baboons with [11C]-(+)-PHNO. - Ragy R. Girgis; Nobumi Miyake; Xiaoyan Xu; Balu Easwaramoorthy; John Castrillon; Roger N. Gunn; Eugenii A. Rabiner; Anissa Abi-Dargham; Mark Slifstein (NeuroImage, 2010)

Predicting the in vivo performance of TSPO PET radioligands using a biomathematical modelling approach. - Qi Guo; David R. Owen; Idriss Bennacef; Eugenii A. Rabiner; Christine A. Parker; Michael Brady 001; Roger N. Gunn (NeuroImage, 2010)

PBR28, PBR06 and PBR111 bind two distinct TSPO sites in human brain tissue. - David R. Owen; Eugenii A. Rabiner; Roger N. Gunn; Paul M. Matthews; Christine A. Parker (NeuroImage, 2010)

Evaluation of the in vivo ED50 for the PET Radioligand, [11C]GSK-215083, in Papio anubis. - Christine A. Parker; Laurent Martarello; Eugenii A. Rabiner; Roger N. Gunn; Marc Laruelle; Mark Slifstein; Vincent J. Cunningham (NeuroImage, 2010)

Graphical analysis of occupancy studies for radioligands with irreversible kinetics. - Eugenii A. Rabiner; Roger N. Gunn (NeuroImage, 2010)

PET measurement of nicotine evoked dopamine release. - Khanum Ridler; Jean-Dominique Gallezot; Richard E. Carson; David Weinzimmer; Mark Slifstein; Roger N. Gunn; Marc Laruelle; Eugenii A. Rabiner (NeuroImage, 2010)

Pharmacokinetic characterization of compounds with increased target residence times using PET. - Cristian A. Salinas; David Weinzimmer; Graham E. Searle; David Labaree; Yu-Shin Ding; Yiyun Huang; Eugenii A. Rabiner; Richard E. Carson; Roger N. Gunn (NeuroImage, 2010)

PET imaging of dopamine D3 receptors in humans with [11C]-(+)-PHNO: dissection of PHNO signal using two highly selective D3 antagonists. - Graham E. Searle; John D. Beaver; Laura E. Iavarone; Robert A. Comley; Massimo Bani; Andri C. Tziortzi; Mark Slifstein; Alan A. Wilson; Roger N. Gunn; Eugenii A. Rabiner; Marc Laruelle (NeuroImage, 2010)

A pseudo-reference region method applied to measurement of GlyT1 occupancy in human brain using [11C]GSK931145 and PET. - Graham E. Searle; Cristian A. Salinas; Santiago Bullich; Joaquim Radua; José Raul Herance; Natalia Lopez-Vilanova; Ricardo Pardo; Magi Farre; Daniele Ouellet; Eugenii A. Rabiner; Ana M. Catafau; Venkatesha Murthy; et al. (NeuroImage, 2010)

Within-subject comparison of the sensitivity of [11C]-(+)-PHNO and [11C]raclopride to amphetamine induced changes in endogenous dopamine in healthy human volunteers. - Paul Shotbolt; Andri C. Tziortzi; Sam Miller 004; Graham E. Searle; Jasper van der Aart; Sergio Abanades; Christophe Plisson; Mickael Huiban; John D. Beaver; Roger N. Gunn; Marc Laruelle; Eugenii A. Rabiner (NeuroImage, 2010)

A combined diffusion tensor imaging (DTI) and [11C]-(+)-PHNO positron emission tomography (PET) study to quantify dopamine D3/D2 receptors in pallidum. - Andri C. Tziortzi; Gwenaëlle Douaud; Paul Shotbolt; Courtney A. Bishop; Graham E. Searle; Marc Laruelle; Eugenii A. Rabiner; Mark Jenkinson; Roger N. Gunn (NeuroImage, 2010)

Effect of cellular compartments on the binding of [3H](+)PhNO to the porcine D2/D3-DAR. - Sarah L. Withey; Roger N. Gunn; Eugenii A. Rabiner; Christine A. Parker (NeuroImage, 2010)

Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy. - Andri C. Tziortzi; Graham E. Searle; Sofia Tzimopoulou; Cristian A. Salinas; John D. Beaver; Mark Jenkinson; Marc Laruelle; Eugenii A. Rabiner; Roger N. Gunn (NeuroImage, 2011)

Spatial-temporal Pharmacokinetic Model Based Registration of 4D Brain PET Data. - Jieqing Jiao; Graham E. Searle; Andri C. Tziortzi; Cristian A. Salinas; Roger N. Gunn; Julia A. Schnabel (STIA, 2012)

Joint estimation of subject motion and tracer kinetic parameters of dynamic PET data in an EM framework. - Jieqing Jiao; Cristian A. Salinas; Graham E. Searle; Roger N. Gunn; Julia A. Schnabel (Image Processing, 2012)

Identifying improved TSPO PET imaging probes through biomathematics: The impact of multiple TSPO binding sites in vivo. - Qi Guo; David R. Owen; Eugenii A. Rabiner; Federico E. Turkheimer; Roger N. Gunn (NeuroImage, 2012)

A Generalised Spatio-Temporal Registration Framework for Dynamic PET Data: Application to Neuroreceptor Imaging. - Jieqing Jiao; Julia A. Schnabel; Roger N. Gunn (MICCAI (1), 2013)

Non linear mixed effects analysis in PET PK-receptor occupancy studies. - Alienor Berges; Vincent J. Cunningham; Roger N. Gunn; Stefano Zamuner (NeuroImage, 2013)

Mathematical modelling of [11C]-(+)-PHNO human competition studies. - Graham E. Searle; John D. Beaver; Andri C. Tziortzi; Robert A. Comley; Massimo Bani; Giulia Ghibellini; Emilio Merlo-Pich; Eugenii A. Rabiner; Marc Laruelle; Roger N. Gunn (NeuroImage, 2013)

A non-linear mixed effect modelling approach for metabolite correction of the arterial input function in PET studies. - Mattia Veronese; Roger N. Gunn; Stefano Zamuner; Alessandra Bertoldo (NeuroImage, 2013)

PET neuroimaging: The elephant unpacks his trunk: Comment on Cumming: "PET neuroimaging: The white elephant packs his trunk?". - Roger N. Gunn; Eugenii A. Rabiner (NeuroImage, 2014)

Spatio-temporal pharmacokinetic model based registration of 4D PET neuroimaging data. - Jieqing Jiao; Graham E. Searle; Andri C. Tziortzi; Cristian A. Salinas; Roger N. Gunn; Julia A. Schnabel (NeuroImage, 2014)

Pseudo-healthy Image Synthesis for White Matter Lesion Segmentation. - Christopher Bowles; Chen Qin; Christian Ledig; Ricardo Guerrero; Roger N. Gunn; Alexander Hammers; Eleni Sakka; David Alexander Dickie; Maria del C. Valdés Hernández; Natalie A. Royle; Joanna M. Wardlaw; Hanneke Rhodius-Meester; et al. (SASHIMI@MICCAI, 2016)

Modelling the progression of Alzheimer's disease in MRI using generative adversarial networks. - Christopher Bowles; Roger N. Gunn; Alexander Hammers; Daniel Rueckert (Image Processing, 2018)

GAN Augmentation: Augmenting Training Data using Generative Adversarial Networks. - Christopher Bowles; Liang Chen 018; Ricardo Guerrero; Paul Bentley; Roger N. Gunn; Alexander Hammers; David Alexander Dickie; Maria del C. Valdés Hernández; Joanna M. Wardlaw; Daniel Rueckert (CoRR, 2018)

GANsfer Learning: Combining labelled and unlabelled data for GAN based data augmentation. - Christopher Bowles; Roger N. Gunn; Alexander Hammers; Daniel Rueckert (CoRR, 2018)

Accuracy and reliability of [11C]PBR28 specific binding estimated without the use of a reference region. - Pontus Plavén-Sigray; Martin Schain; Francesca Zanderigo; Eugenii A. Rabiner; Roger N. Gunn; R. Todd Ogden; Simon Cervenka (NeuroImage, 2019)